Methoden vergleichen
Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.
| Minnesota Living with Heart Failure Questionnaire (MLHFQ)× | Duke Activity Status Index (DASI)× | |
|---|---|---|
| Fachgebiet | Kardiologie | Kardiologie |
| Familie | Process / pipeline | Process / pipeline |
| Entstehungsjahr≠ | 1987 | 1989 |
| Urheber≠ | Timothy S. Rector | Mark A. Hlatky |
| Typ | Self-report questionnaire | Self-report questionnaire |
| Wegweisende Quelle≠ | Rector, T. S., Kubo, S. H., & Cohn, J. N. (1987). Patients' self-assessment of their congestive heart failure. Part 2: Content, reliability and responsiveness of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure, 3(5), 198–209. link ↗ | Hlatky, M. A., Boineau, R. E., Higginbotham, M. B., Lee, K. L., Mark, D. B., Califf, R. M., Cobb, F. R., & Pryor, D. B. (1989). A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index). American Journal of Cardiology, 64(10), 651–654. DOI ↗ |
| Aliasnamen | MLHFQ | DASI |
| Verwandt | 4 | 4 |
| Zusammenfassung≠ | The Minnesota Living with Heart Failure Questionnaire (MLHFQ) is a 21-item self-report measure that quantifies the multidimensional burden of heart failure on patients' daily living and quality of life. Developed by Rector, Kubo, and Cohn in 1987, the MLHFQ is the most widely used disease-specific QoL instrument in heart failure research and clinical practice, valued for its brevity, sensitivity to treatment response, and predictive value for prognosis. | The Duke Activity Status Index (DASI) is a 12-item self-report questionnaire that estimates functional capacity—the maximum oxygen consumption (VO2 max) a patient can achieve—based on their ability to perform common daily activities. Developed by Hlatky and colleagues in 1989, the DASI provides a non-invasive assessment of exercise tolerance and cardiovascular fitness equivalent to formal exercise stress testing, making it invaluable for risk stratification, treatment planning, and prognosis in cardiac and pulmonary populations. |
| ScholarGateDatensatz ↗ |
|
|